Total Payments
$5,357
2024 Payments
$2,290
Companies
49
Transactions
215
Medicare Patients
1,855
Medicare Billing
$338,565
Payment Breakdown by Category
Food & Beverage$3,576 (66.7%)
Other$1,097 (20.5%)
Education$684.71 (12.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,576 | 195 | 66.7% |
| Long term medical supply or device loan | $1,097 | 11 | 20.5% |
| Education | $684.71 | 9 | 12.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,457 | 48 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $342.44 | 16 | $0 (2023) |
| PFIZER INC. | $322.54 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $285.89 | 11 | $0 (2024) |
| Amgen Inc. | $273.60 | 5 | $0 (2023) |
| Astellas Pharma US Inc | $217.77 | 6 | $0 (2024) |
| Seagen Inc. | $216.50 | 10 | $0 (2023) |
| GENZYME CORPORATION | $197.29 | 10 | $0 (2024) |
| ABBVIE INC. | $172.91 | 5 | $0 (2024) |
| Kite Pharma, Inc. | $152.99 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,290 | 78 | Novartis Pharmaceuticals Corporation ($1,269) |
| 2023 | $1,276 | 74 | Novartis Pharmaceuticals Corporation ($143.01) |
| 2022 | $845.39 | 46 | E.R. Squibb & Sons, L.L.C. ($117.35) |
| 2021 | $212.57 | 3 | E.R. Squibb & Sons, L.L.C. ($100.99) |
| 2020 | $99.99 | 1 | Amgen Inc. ($99.99) |
| 2019 | $257.01 | 9 | AbbVie, Inc. ($99.95) |
| 2018 | $364.11 | 3 | Kite Pharma, Inc. ($125.00) |
| 2017 | $12.40 | 1 | The Medicines Company ($12.40) |
All Payment Transactions
215 individual payment records from CMS Open Payments — Page 2 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/18/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 09/16/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: Oncology | ||||||
| 09/13/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/11/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Oncology | ||||||
| 08/29/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: ONCOLOGY | ||||||
| 08/27/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $49.99 | General |
| 08/23/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 08/08/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: Oncology | ||||||
| 08/08/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Oncology | ||||||
| 08/08/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Rare Disease | ||||||
| 07/31/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: ONCOLOGY | ||||||
| 07/29/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Immunology | ||||||
| 07/23/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: ONCOLOGY | ||||||
| 07/15/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 07/11/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $2.42 | General |
| Category: Oncology | ||||||
| 07/10/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Oncology | ||||||
| 07/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $17.70 | General |
| 06/20/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Oncology | ||||||
| 06/13/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 06/10/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $8.22 | General |
| Category: Oncology | ||||||
| 06/10/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $3.23 | General |
| Category: Oncology | ||||||
| 05/30/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: Oncology | ||||||
| 05/29/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $13.08 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 628 | 1,485 | $347,307 | $127,270 |
| 2022 | 8 | 753 | 1,531 | $351,798 | $137,277 |
| 2021 | 9 | 428 | 743 | $168,266 | $69,756 |
| 2020 | 2 | 46 | 65 | $10,993 | $4,262 |
Total Patients
1,855
Total Services
3,824
Medicare Billing
$338,565
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 153 | 595 | $159,441 | $63,406 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 256 | 633 | $123,477 | $44,355 | 35.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 48 | 48 | $18,606 | $6,253 | 33.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 44 | 44 | $15,156 | $4,022 | 26.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 28 | $14,252 | $3,690 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 56 | 63 | $8,028 | $2,728 | 34.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 26 | $6,604 | $2,276 | 34.5% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Facility | 2023 | 25 | 48 | $1,743 | $540.48 | 31.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 184 | 580 | $149,060 | $63,452 | 42.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 331 | 676 | $125,060 | $47,724 | 38.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 65 | 65 | $24,180 | $9,014 | 37.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 66 | 66 | $19,602 | $6,403 | 32.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 26 | $13,234 | $3,896 | 29.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 25 | 48 | $12,192 | $3,721 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 39 | 46 | $5,566 | $2,232 | 40.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 20 | 24 | $2,904 | $833.65 | 28.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 181 | 332 | $61,420 | $25,449 | 41.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 83 | 218 | $56,026 | $24,684 | 44.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 27 | 29 | $13,493 | $4,338 | 32.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 32 | 45 | $8,410 | $3,658 | 43.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 23 | 23 | $8,556 | $3,272 | 38.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 30 | 30 | $8,910 | $3,046 | 34.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 26 | 40 | $4,977 | $2,278 | 45.8% |
| 99220 | Hospital observation care, typically 70 minutes | Office | 2021 | 14 | 14 | $3,780 | $2,024 | 53.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 12 | 12 | $2,694 | $1,008 | 37.4% |
About Amit Bansal
Amit Bansal is a Internal Medicine healthcare provider based in Troy, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2015. The National Provider Identifier (NPI) number assigned to this provider is 1356736433.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amit Bansal has received a total of $5,357 in payments from pharmaceutical and medical device companies, with $2,290 received in 2024. These payments were reported across 215 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($3,576).
As a Medicare-enrolled provider, Bansal has provided services to 1,855 Medicare beneficiaries, totaling 3,824 services with total Medicare billing of $338,565. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Troy, OH
- Active Since 04/05/2015
- Last Updated 04/16/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1356736433
Products in Payments
- KISQALI (Drug) $1,210
- PADCEV (Biological) $269.75
- ELIQUIS (Drug) $172.08
- Blincyto (Biological) $158.92
- DARZALEX (Biological) $141.37
- Yescarta (Drug) $125.00
- IMBRUVICA (Drug) $123.44
- BEVYXXA (Drug) $116.05
- OPDIVO (Biological) $100.81
- Venclexta (Drug) $99.95
- TAZVERIK (Drug) $99.00
- Doptelet (Drug) $90.95
- JEVTANA (Drug) $88.99
- SARCLISA (Biological) $81.01
- IBRANCE (Drug) $73.91
- FLOWTRIEVER CATHETER, S (Device) $67.08
- KEYTRUDA (Biological) $62.53
- MONOFERRIC (Drug) $62.09
- XTANDI (Drug) $60.54
- ULTOMIRIS (Biological) $57.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Troy
Dr. Neil Fraser, Md, MD
Internal Medicine — Payments: $180,276
Internal Medicine $180,276
Dr. John Calado, Do, DO
Internal Medicine — Payments: $152,221
Internal Medicine $152,221
Michael Doyle, Md, MD
Internal Medicine — Payments: $85,884
Internal Medicine $85,884
Dr. Jay Sandberg, D.o, D.O
Internal Medicine — Payments: $28,867
Internal Medicine $28,867
Dr. Mohammed Kabir, Md, MD
Internal Medicine — Payments: $26,648
Internal Medicine $26,648
Dr. Noor Bunney, Md, MD
Internal Medicine — Payments: $21,394
Internal Medicine $21,394